Immunoglobulin

Gamimune N 5%

BrazilCancelledAuthorised 25 Jan 1995

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Gamimune N 10% (IV)Canada · 100 MG / ML · Solution · Talecris Biotherapeutics INCSame brand
Gamimune N 5% (IV)Canada · 50 MG / ML · Solution · Talecris Biotherapeutics INCSame brand
Gamimune N Inj 5% (IV)Canada · 50 MG / ML · Liquid · Cutter Med & Biol, Division of Miles Canada LTD.Same brand
A T G Fresenius "Solution"Taiwan · 注射劑 · 海喬國際股份有限公司Same form
Gammagard S/D for InjectionSingapore · 48-56 mg/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Immunoglobulin

Gamimune N 5%

BrazilCancelledAuthorised 25 Jan 1995

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

OCTAGAM SOLUTION FOR INFUSION 50 mg/mlSingapore · 50 mg/ml · injection · Wellchem Pharmaceuticals Pte LTD

PENTAGLOBIN INJECTION 50 mg/mlSingapore · 50 mg/ml · injection · Grifols Asia Pacific Pte. LTD.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Immunoglobulin
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 25 Jan 1995
Registration: 100820105
Marketing authorisation holder: Abbott Produtos Para Saúde Ltda.
Procedure: Registered

Anvisa

Armoglobulina PImmunoglobulinBrazilCancelled

Atg FreseniusImmunoglobulinBrazilCancelled

BeriglobinaImmunoglobulinBrazilCancelled

Endobulin KiovigImmunoglobulinBrazilCancelled

HyqviaImmunoglobulinBrazilCancelled

Ig Vena N I VImmunoglobulinBrazilCancelled